Express Pharma - Page 195 of 2181 - Express Pharma

Lupin receives Great Place To Work certification across global operations

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

COPD market to reach $30.8 billion in 7MM by 2033: GlobalData

mRNA licensing agreements rise 800% in value as confidence grows beyond vaccines

OneSource receives equity commitments of Rs 8,010 Mn at a pre-money equity valuation of $ 1.65 Bn

International life sciences regulations: How CROs, CMOs, and CDMOs are primed for advantage

A new photocatalyst can efficiently degrade broad-spectrum antibiotics

CMO Symbiosis acquires 20,000 sq/ft facility, £1.2m financed by Barclays Corporate Bank

USV launches heart failure medication at ₹8 per 50mg tablet

Lupin launches first generic of Pred Forte in the US

How warehouse automation is creating impact on medical distribution

Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease